PAH rs281865444: Understanding Phenylketonuria Carrier Status
The rs281865444 variant is a specific change located within the PAH gene, which provides instructions for the phenylalanine hydroxylase enzyme. This variant is recognized in clinical databases as being associated with carrier status for phenylketonuria (PKU), an inherited metabolic disorder.
What each genotype means
Typical PAH gene profile
This genotype represents the common, non-variant form of the PAH gene at this location. Individuals with this profile do not carry this specific genetic variant associated with phenylketonuria.
This is the most common genotype observed in the general population.
Phenylketonuria carrier status
This genotype indicates you are a carrier of a variant associated with phenylketonuria. Carriers are typically unaffected, but you should discuss the implications of this result with a genetic counselor or clinician, especially if you are planning a family.
This genotype is rare in the general population.
Potential phenylketonuria risk
This genotype indicates the presence of two copies of the variant associated with phenylketonuria. You should consult with a medical professional or metabolic specialist to understand what this means for your health, as this variant is considered probably pathogenic.
This genotype is extremely rare in the general population.
What is the rs281865444 Variant?
The rs281865444 variant is a single nucleotide polymorphism (SNP) found within the PAH gene, which is located on chromosome 12. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is cataloged in public databases like dbSNP and ClinVar due to its potential clinical significance. When researchers identify such variants, they look at how the change in the DNA sequence might affect the function of the resulting protein. Because this variant is situated within the PAH gene, it is studied in the context of how the body processes the amino acid phenylalanine. Understanding the location and nature of this variant is the first step in determining its role in human health and its potential impact on metabolic processes.
The Role of the PAH Gene
The PAH gene is responsible for producing an enzyme called phenylalanine hydroxylase. This enzyme is essential for the body to break down phenylalanine, an amino acid found in many protein-rich foods. Under normal conditions, the enzyme converts phenylalanine into tyrosine, another amino acid that the body uses for various important functions. When the PAH gene contains certain pathogenic variants, the activity of this enzyme can be significantly reduced or absent. This leads to an accumulation of phenylalanine in the body, which can be toxic if levels become too high. Phenylketonuria (PKU) is an autosomal recessive condition caused by these types of variants. Because it is recessive, an individual typically needs to inherit a pathogenic variant from both parents to experience the symptoms of the disorder.
Research and Clinical Evidence
Scientific research classifies rs281865444 as a variant associated with phenylketonuria carrier status. Being a carrier means that an individual possesses one copy of a variant that could contribute to PKU, but they do not typically exhibit the symptoms of the condition themselves because they have a second, functional copy of the gene. The evidence strength for this variant is considered moderate, meaning that while it is linked to the condition in clinical literature, ongoing research continues to refine our understanding of its specific impact. It is important to note that clinical databases aggregate information from various studies, and the interpretation of such variants can evolve as more data becomes available. Researchers use this information to help families understand their genetic risks, particularly when planning for the health of future generations.
Population Frequency
The rs281865444 variant is classified as rare in the general population. Genetic frequency can vary significantly across different ancestral groups, and because this variant is not common, it is not frequently observed in large-scale population studies. The rarity of this variant means that most individuals will not carry it, and its presence is usually identified through targeted clinical testing rather than routine screening. Because the prevalence of PKU and its associated variants differs by geographic region and ethnicity, the frequency of this specific SNP may be higher in certain populations than in others. Geneticists often study these patterns to better understand the evolutionary history of metabolic disorders and to improve the accuracy of genetic counseling for diverse groups of people.
What This Information Means for You
If you have received information about this variant, it is important to understand that it does not constitute a medical diagnosis. Being a carrier of a PKU-associated variant is a common finding in genetic testing and does not mean you have the disorder. If you are concerned about your results or your family history, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help interpret the results in the context of your overall health and family history. You should never make changes to your diet or medical regimen based on genetic data without professional guidance. A clinician can provide personalized advice, explain the implications of carrier status, and discuss whether further testing is necessary for you or your family members.
How common is this variant?
The rs281865444 variant is considered rare across global populations, with its frequency varying depending on ancestral background.
Frequently asked questions
What is a carrier of phenylketonuria?
A carrier of phenylketonuria (PKU) has one copy of a pathogenic PAH gene variant and one normal copy. Carriers typically do not show symptoms of PKU because their functional gene copy produces enough enzyme to process phenylalanine.
Does having this variant mean I have PKU?
No, having this variant does not mean you have PKU. PKU is an autosomal recessive condition, which generally requires inheriting a pathogenic variant from both parents to manifest the disorder.
Should I change my diet if I am a carrier?
There is no medical recommendation for carriers to change their diet. You should consult with your doctor or a registered dietitian before making any significant changes to your nutritional intake.
How can I find out if my partner is also a carrier?
If you are concerned about the risk of passing a condition to children, you can speak with a genetic counselor. They can facilitate carrier screening for your partner to determine the likelihood of having a child with the condition.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs281865444?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAH
This variant is associated with carrier status for phenylketonuria, a metabolic disorder.
A missense variant (c.1222C>T, p.Arg408Trp) that disrupts phenylalanine hydroxylase activity, defining carrier status for classic autosomal recessive phenylketonuria across Eastern and Northern Europe.
A splice-donor site variant (c.1066-11G>A, legacy IVS10nt-11) causing phenylalanine hydroxylase deficiency and serving as a frequent carrier screening marker for phenylketonuria.
Classic severe phenylalanine hydroxylase deficiency splice donor variant (c.1066-11G>A) causing autosomal recessive phenylketonuria.
Missense transition (p.Arg408Trp) causing marked enzymatic loss in phenylalanine hydroxylase and severe classic phenylketonuria when inherited bi-allelically.
Well-characterized missense mutation (p.Arg408Trp) conferring carrier status for autosomal recessive phenylketonuria.